Important Benefits of EBUS-TBNA in Assessing PD-L1 Expression in NSCLC

被引：0
|
作者：
Centanaro, Gianna Vargas [1 ]
Forcen, Elena [1 ]
Morales, Beatriz [1 ]
Alvarez-Sala, J. L. [1 ]
Calle, Myriam [1 ]
Bernabe, M. Jose [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Lung cancer; Bronchoscopy; Lung cancer - diagnosis;
D O I：
10.1183/13993003.congress-2020.1695
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1695
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1 expression in NSCLC - our institution experience
    Krajnovic, B.
    Sekerus, V.
    Stojanovic, G.
    Zaric, B.
    Lazin, S.
    Lovrenski, A.
    Maksimovic, S.
    Tegeltija, D.
    VIRCHOWS ARCHIV, 2021, 479 : S161 - S161
  • [32] PD-LI Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA
    Fernandez-Bussy, Sebastian
    Pires, Yumay
    Labarca, Gonzalo
    Vial, Macarena R.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (05): : 290 - 292
  • [33] PD-L1 in NSCLC cytology
    Kovacevic, M.
    Kern, I.
    Gabric, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
    Zhang, Jie
    Gao, Jing
    Li, Yanyan
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Han, Jindi
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Shen, Lin
    Fang, Jian
    THORACIC CANCER, 2015, 6 (04) : 534 - 538
  • [35] Expression of PD-L1 in plasma exosomes of NSCLC patients and its associations with PD-L1 expression of corresponding tumour tissues
    Yu, S.
    Shi, M.
    Feng, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] High SUVmax Is an Independent Predictor of Higher Diagnostic Accuracy of ROSE in EBUS-TBNA for Patients with NSCLC
    Chen, Ying-Yi
    Huang, Hsin-Ya
    Lin, Chi-Yi
    Chen, Kuan-Liang
    Huang, Tsai-Wang
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [37] WHAT IS THE RATE OF SURGICAL UPSTAGING FOLLOWING NEGATIVE EBUS-TBNA OF MEDIASTINAL LYMPH NODES FOR NSCLC?
    Antippa, Phillip N.
    Mehta, Marzi G.
    Irving, Louis
    Steinfort, Daniel
    Cheang, Mun Yoong
    Tsui, Alpha
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S659 - S659
  • [38] Performance of EBUS-TBNA in NSCLC mediastinal staging stratified according to ACCP radiographic groups on CT
    Edwards, T.
    Al-Najjar, H.
    Crosbie, P.
    Martin, J.
    Booton, R.
    Evison, M.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S92 - S92
  • [39] Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC
    John, Nikolaus
    Schlintl, Verena
    Sassmann, Teresa
    Lindenmann, Joerg
    Fediuk, Melanie
    Wurm, Robert
    Douschan, Philipp
    Zacharias, Martin
    Kalson, Lipika
    Posch, Florian
    Absenger, Gudrun
    Brcic, Luka
    Jost, Philipp J.
    Terbuch, Angelika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [40] Various impacts of driver mutations on the PD-L1 expression of NSCLC
    Chu, Cheng-Hsiang
    Huang, Yen-Hsiang
    Lee, Po-Hsin
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Su, Kang-Yi
    Yu, Sung-Liang
    Tseng, Jeng-Sen
    Yang, Tsung-Ying
    Chang, Gee-Chen
    PLOS ONE, 2022, 17 (08):
12345